Resumo

VILLA-SALDARRIAGA, María P; GOMEZ-RAMIREZ, Luz A; MIRANDA-ARBOLEDA, Andrés F  e  SAAVEDRA-GONZALEZ, Yesid A. High dose cytarabine induced myopericarditis: When the heart debilitates but the fight against cancer must be strong. Iatreia [online]. 2022, vol.35, n.2, pp.200-204.  Epub 07-Fev-2023. ISSN 0121-0793.  https://doi.org/10.17533/udea.iatreia.140.

Knowledge about cytarabine induced cardiotoxicity is scarce. We present the clinical case of a 51-year-old patient with past medical history of Acute Myeloid Leukemia managed with high doses of cytarabine and who developed acute myopericarditis as a complication. After support management in intensive care unit, specific cardioprotective heart failure therapy was started and, due to the high possibility of requiring high doses of cytarabine in subsequent oncological management, therapy with Non-Steroidal Anti-inflammatory drugs and colchicine was given to reduce the risk of myopericarditis recurrence. We present the clinical case and a diagnostic strategy for patients with high doses of cytarabine and pericardial and myocardial involvement.

Palavras-chave : Cytarabine; Myocarditis; Pericarditis.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )